1,171 results on '"Carcinoma -- Care and treatment"'
Search Results
1052. Diagnosis and treatment of thyroid carcinoma reviewed
1053. Diagnosis and treatment of thyroid carcinoma reviewed
1054. Platinum-based chemotherapy is efficacious in uterine papillary serous carcinoma
1055. Platinum-based chemotherapy is efficacious in uterine papillary serous carcinoma
1056. Platinum-based chemotherapy is efficacious in uterine papillary serous carcinoma
1057. Cases of small cell carcinoma of the esophagus analyzed
1058. Surgical treatment of salivary duct carcinoma of submandibular gland reviewed
1059. Surgical treatment of salivary duct carcinoma of submandibular gland reviewed
1060. Surgical treatment of salivary duct carcinoma of submandibular gland reviewed
1061. Combined therapies affected quality of life in nasopharyngeal carcinoma patients
1062. Combined therapies affected quality of life in nasopharyngeal carcinoma patients
1063. Combined therapies affected quality of life in nasopharyngeal carcinoma patients
1064. Use of chemoradiotherapy to treat esophageal carcinoma investigated
1065. Adjuvant systemic therapy used to treat male breast carcinoma
1066. Methods for enumerating circulating tumor cells in carcinoma patients compared
1067. Surgeon perspectives about local therapy for breast carcinoma shared
1068. Surgeon perspectives about local therapy for breast carcinoma shared
1069. Distribution of positive lymph nodes in patients with N0 oropharyngeal carcinoma assessed
1070. Surgeon perspectives about local therapy for breast carcinoma shared
1071. Gemcitabine and irinotecan treated patients with carcinoma of an unknown primary site
1072. Gemcitabine and irinotecan treated patients with carcinoma of an unknown primary site
1073. Gemcitabine and irinotecan treated patients with carcinoma of an unknown primary site
1074. Pharmacokinetics of S-1 plus cisplatin studied in patients with advanced gastric carcinoma
1075. Chemoradiotherapy improved tumor control of nasopharyngeal carcinoma
1076. Papillary thyroid carcinoma after recombinant GH therapy for Turner syndrome
1077. Pharmacokinetics of S-1 plus cisplatin studied in patients with advanced gastric carcinoma
1078. Chemoradiotherapy improved tumor control of nasopharyngeal carcinoma
1079. Papillary thyroid carcinoma after recombinant GH therapy for Turner syndrome
1080. Pharmacokinetics of S-1 plus cisplatin studied in patients with advanced gastric carcinoma
1081. Chemoradiotherapy improved tumor control of nasopharyngeal carcinoma
1082. Papillary thyroid carcinoma after recombinant GH therapy for Turner syndrome
1083. Adjuvant therapy with chemotherapy increases survival of women with serous carcinoma
1084. Adjuvant therapy with chemotherapy increases survival of women with serous carcinoma
1085. Adjuvant therapy with chemotherapy increases survival of women with serous carcinoma
1086. Exclusive low-dose-rate brachytherapy used to treat T2N0 mobile tongue carcinoma
1087. CT and FDG-PET image fusion impacted treatment planning and management of esophageal carcinoma
1088. Paclitaxel was well tolerated but showed limited efficacy in bronchioloalveolar carcinoma
1089. Exclusive low-dose-rate brachytherapy used to treat T2N0 mobile tongue carcinoma
1090. CT and FDG-PET image fusion impacted treatment planning and management of esophageal carcinoma
1091. Paclitaxel was well tolerated but showed limited efficacy in bronchioloalveolar carcinoma
1092. Exclusive low-dose-rate brachytherapy used to treat T2N0 mobile tongue carcinoma
1093. CT and FDG-PET image fusion impacted treatment planning and management of esophageal carcinoma
1094. Paclitaxel was well tolerated but showed limited efficacy in bronchioloalveolar carcinoma
1095. Low-dose GM-CSF used as salvage therapy in breast and genital tract carcinoma
1096. Brachytherapy is replacing other treatment modalities for prostate carcinoma
1097. Low-dose GM-CSF used as salvage therapy in breast and genital tract carcinoma
1098. Brachytherapy is replacing other treatment modalities for prostate carcinoma
1099. Low-dose GM-CSF used as salvage therapy in breast and genital tract carcinoma
1100. Brachytherapy is replacing other treatment modalities for prostate carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.